You are absolutely correct! The original trademark application was named incorrectly--the name to be trademarked was intended to be HemaXellerate from the very beginning. So, the application was abandoned as they did not intend to trademark HemXellerate. Just HemaXellerate. And all is proceeding with that as they have anticipated.